Immune cell recruitment and activation within the GBM microenvironment may be influenced by LYZ, potentially impacting tumor-immune interactions and disease progression, as indicated by the variations in immune cell abundance between high and low LYZ expression groups. This evidence concerns the gene LYZ and neoplasm.